Botha, Leslie CarolHoly Hormones Journal
Human Papillomavirus Vaccine have widely acclaimed as a sweeping vaccine innovation for the universal benefit of all the women and girls. Every year, thousands of women develop cervical cancer, and thousands die from the disease. Avast majority of these deaths occur in low and middle-income countri...
Fig. 1 is based on women 18–25 years old; Fig. 2 is based on girls 10–18 years old. Females are both seronegative and PCR DNA negative for the vaccine relevant HPV types. While an increased interval between the initial two doses is logistically easier, the immediate antibody titers ...
5.PublichealthneedfortherapeuticHPVvaccinesinthecontextofexistinginterventions10 5.1Implementationandscale-upofprophylacticHPVvaccineprogrammes10 5.2Implementationandscale-upofcervicalcancerscreeningandtreatment10 5.3Implementationandscale-upofcervicalcancermanagement12 ...
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. Importance Global use of human papillomavirus (HPV) vaccines to prevent cervical cancer is impeded by cost. A 2-dose schedule for girls may be possible.Obj... SRM Dobson...
The 2-doses vac- cination schedule appeared to be the most cost-effective assuming the vaccines could provide protection for more than 20 years [50]. The WHO has suggested that individu- als between the ages of 9 and 15 receiving two doses of the HPV vaccine at least six months ...
However, some studies suggested that it may be also clinically useful to identify other HPV types such as HPV 31, 33, 33/58 (combined), which showed comparable or increased risk for the development of CIN 2+ [65–67]. Conclusions The nonavalent HPV vaccine appears to be safe and ...
1. HPV vaccine suspension in India. [J] . Feinberg M The Lancet . 2010,第9753期 机译:HPV疫苗在印度的悬浮液。 2. Tracking the global spread of vaccine sentiments: The global response to Japan's suspension of its HPV vaccine recommendation [J] . Larson Heidi J., Wilson Rose, Hanley...
An increase in worldwide HPV vaccination could be facilitated if fewer than three doses of vaccine are as effective as three doses. We originally aimed to compare the immunogenicity and frequency of persistent infection and cervical precancerous lesions caused by vaccine-targeted HPV after vaccinatio...
2). It took less than a decade for 80% of HICs to introduce the HPV vaccine. LMICs not only started introducing later, they introduce at lower pace, and they are also more than twice as many LMICs than HICs, so they still lag far behind with only 41% of LMICs have introduced by ...